Physician
DR. Jamie A. Lipeles, a Professional Medical Corporation
DR. Jamie A. Lipeles, a Professional Medical Corporation was paid $6.73M by Medicaid between Jan 2018 and Nov 2024, across 69 billing codes. Its largest line is J7298, Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg — 18% of everything it billed.
33Billing provider infoDR. JAMIE A. LIPELES, A PROFESSIONAL MEDICAL CORPORATION
HAWTHORNE, CA 90250
HAWTHORNE, CA 90250
33aNPI1760756860assigned 03/07/2012
33bProvider typeObstetrics & Gynecology Physician
28Total paid$6.73M
24GClaims171,478
24DCodes billed69
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Obstetrics & Gynecology Physician providers in California
Rank by total paid#15 of 791
Median peer was paid$67K
This provider vs. median101×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,989 | $303K | |
| 2019 | 14,905 | $495K | |
| 2020 | 18,839 | $909K | |
| 2021 | 24,864 | $1.08M | |
| 2022 | 25,119 | $901K | |
| 2023 | 36,439 | $1.49M | |
| 2024incomplete | 43,323 | $1.55M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 18% | 1,728 | 1,716 | $1.19M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 27,552 | 23,545 | $1.08M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 10% | 12,075 | 12,001 | $685K |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | 8.4% | 12,697 | 7,558 | $564K |
| J7296 | Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg | 6.4% | 512 | 511 | $434K |
| 58300 | 5.7% | 5,185 | 2,630 | $387K | |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 3.9% | 682 | 680 | $263K |
| 58558 | 2.6% | 2,436 | 1,232 | $174K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 2.1% | 2,908 | 1,530 | $142K |
| 76830 | Ultrasound, transvaginal | 2.0% | 2,894 | 2,869 | $137K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1.8% | 2,495 | 2,475 | $123K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.8% | 3,335 | 1,726 | $118K |
57 more codes
| 99000 | 1.7% | 21,866 | $114K | |
| Z1034 | 1.6% | 1,855 | $105K | |
| 57454 | 1.5% | 2,492 | $103K | |
| 81002 | 1.5% | 21,917 | $101K | |
| 81025 | 1.5% | 9,795 | $100K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.4% | 1,730 | $94K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1.2% | 1,100 | $78K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,174 | $52K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 825 | $52K |
| 58301 | <1% | 2,109 | $50K | |
| 76813 | <1% | 576 | $48K | |
| 76801 | <1% | 671 | $40K | |
| 88150 | <1% | 2,449 | $38K | |
| 59514 | <1% | 107 | $37K | |
| 58110 | <1% | 1,183 | $36K | |
| 58100 | <1% | 1,393 | $30K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | <1% | 42 | $29K |
| 59425 | <1% | 979 | $28K | |
| 90715 | <1% | 1,010 | $27K | |
| 57505 | <1% | 1,098 | $27K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 444 | $24K |
| H1002 | Prenatal care, at risk enhanced service; care coordination | <1% | 310 | $22K |
| 59025 | Fetal non-stress test | <1% | 917 | $18K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 921 | $17K |
| 90651 | <1% | 71 | $15K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,744 | $15K |
| H1000 | Prenatal care, at-risk assessment | <1% | 140 | $13K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 376 | $12K |
| 87210 | <1% | 2,697 | $12K | |
| 59430 | <1% | 271 | $10K | |
| H2000 | Comprehensive multidisciplinary evaluation | <1% | 130 | $9K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 675 | $8K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 2,675 | $7K |
| 99201 | <1% | 511 | $7K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 730 | $7K |
| J7297 | Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg | <1% | 12 | $7K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 258 | $7K |
| 11981 | <1% | 80 | $6K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 1,854 | $6K |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 596 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 910 | $5K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 94 | $3K |
| 99205 | Prolong outpt/office vis | <1% | 26 | $2K |
| Z6500 | <1% | 16 | $2K | |
| Z1032 | <1% | 17 | $2K | |
| 99441 | <1% | 194 | $2K | |
| 96156 | <1% | 282 | $2K | |
| 11982 | <1% | 26 | $1K | |
| 97803 | <1% | 195 | $1K | |
| 99401 | <1% | 85 | $507.49 | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 157 | $272.88 |
| 57160 | <1% | 12 | $189.08 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 79 | $135.01 |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 13 | $129.10 |
| Z6400 | <1% | 16 | $121.12 | |
| S9452 | Nutrition classes, non-physician provider, per session | <1% | 17 | $100.36 |
| 99024 | 0% | 57 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLIPELES, JAMIE (PRESIDENT)